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Substantial evidence suggests that the behavioral and reinforcing effects of cocaine can be
mediated by the central dopaminergic systems. Repeated injections of cocaine produce an
increase in locomotor activity and the expression of tyrosine hydroxylase (TH) in the main
dopaminergic areas. Protoberberine alkaloids affect neuronal functions. Coptidis rhizoma (CR)
and its main compound, berberine (BER) reduced the dopamine content in the central nervous
system. In order to investigate the effects of CR or BER on the repeated cocaine-induced
neuronal and behavioral alterations, we examined the influence of CR or BER on the repeated
cocaine-induced locomotor activity and the expression of TH in the brain by using
immunohistochemistry. Male SD rats were given repeated injections of saline or cocaine
hydrochloride (15mg/kg, i.p. for 10 consecutive days) followed by one challenge injection on
the 4th day after the last daily injection. Cocaine challenge (15mg/kg, i.p) produced a larger
increase in locomotor activity and expression of TH in the central dopaminergic areas.
Pretreatment with CR (50, 100, 200 and 400mg/kg, p.o.) and BER (200mg/kg, p.o.) 30min
before the daily injections of cocaine significantly inhibited the cocaine-induced locomotor
activity as well as TH expression in the central dopaminergic areas. Our data demonstrate that
the inhibitory effects of CR and BER on the repeated cocaine-induced locomotor activity were
closely associated with the reduction of dopamine biosynthesis and post-synaptic neuronal
activity. These results suggest that CR and BER may be effective for inhibiting the behavioral
effects of cocaine by possibly modulating the central dopaminergic system.
Keywords: cocaine–berberine–Coptidis rhizome–locomotor activity–tyrosine hydroxylase–
ventral tegmental area.
Introduction
Repeated exposure to psychostimulants induces sensitiza-
tion to their behavioral stimulant effects. Behavioral
sensitization is the enhanced motor-stimulant response
that occurs with repeated exposure to such psychostimu-
lants as cocaine or amphetamine (1,2).
Cocaine is a potent and widely abused psychostimulant
that exerts behavioral and neuropharmacologic effects;
these effects may be mediated by the central dopaminergic
systems. Especially, the mesolimbic system from the ventral
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properly cited.tegmental area (VTA) to the nucleus accumbens (NAc),
one of the main central dopaminergic systems, has been
implicated in the processes of drug addiction and this
includes behavioral sensitization (3,4). For example, many
studies reveal that the reinforcing effects of cocaine are
related to the blockade of the dopamine (DA) reuptake
systems (5) and the consequent increases in binding of DA
to its post-synaptic receptors (6). The inhibition of DA re-
uptake has been demonstrated in several brain nuclei such
as the NAc, the striatum, the VTA and the medial
prefrontal cortex (3,7–9). DA receptor antagonists also
block the cocaine-induced increases of locomotor activity
and stereotypy, the decrease of food intake (10) and they
block the cocaine-induced reinstatement of drug seeking
behavior (11,12). In addition, several studies have
shown that repeated exposure to cocaine produced
the expression of tyrosine hydroxylase (TH) enzyme
activity for DA biosynthesis in mesolimbic DA
pathways (13,14).
Coptidis rhizoma (Coptis chinensis FRANCH, CR)
has been widely used as a Korean traditional medicine
for hundreds of years. CR exerts therapeutic effects on
disorders such as anxiety, depression and substance abuse
in human and animal studies (15,16) and CR and its
main compound, berberine (BER) produced a variety of
biological effects on the central nervous system (17–20).
In particular, protoberberine alkaloids such as BER,
palmatine and coptisine inhibited DA biosynthesis
(21,22). BER reduces the dopamine content in PC12
cells (18,23).
However, the effects of CR or BER on cocaine-induced
neurochemical and behavioral alterations have not been
investigated. Therefore, in the present study,
we determined to examine whether CR or BER could
affect the repeated cocaine-induced locomotor activity.
The expressions of TH in the VTA were also examined
by using immunohistochemical methods in order to
determine a possible mechanism underlining the suppres-
sive effects of CR and BER on cocaine-induced
behavioral sensitization in rats.
Methods
Subject
Male Sprague–Dawley rats weighing 260–270g each were
obtained from Samtaco Animal Corp. (Seoul, Korea).
The experiment began at least 7 days after their
arrival. Rats were maintained on ad libitum food
and water and they were maintained on a 12h
light-dark cycle (lights on at 7:00) at an ambient
temperature of 22–24 C with a controlled relative
humidity of 55%. All experiments were approved by
the Kyung Hee University Institutional Animal Care and
Use Committee.
Preparation of the Drugs and the Methanol Extracts of
Coptidis Rhizoma
CR was purchased from an oriental drug store
(Jungdo Inc. Seoul, Korea). The voucher specimens
(no. KH-CR01) are deposited at the herbarium located
in the College of Oriental Medicine, Kyung Hee
University. CR (100g) was cut into small pieces and
extracted three times in a reflux condenser for 24h
each time using 85% methanol. The solutions were
combined, filtered through Whatman no. 1 filter paper
and concentrated using a rotary vacuum evaporator, this
was followed by lyophilization. The yield was 12.8%
(w/w). CR consists of the major active component,
berberine (4–7%) and also of small amount of columba-
mine, coptisine, groenlandicine, berberastine and
thalifendine. Cocaine hydrochloride (Macharlan, Smiss
Limit, UK) and berberine (Sigma, St Louis MO, USA)
were obtained from the standard commercial
suppliers. Cocaine hydrochloride was dissolved in 0.9%
saline and CR and berberine were dissolved in
distilled water.
Experimental Design
The experiment consisted of three phases: a 10day
developmental phase, a 3day withdrawal phase and
a 1day challenging phase. The experiment was designed
to investigate the effect of CR and BER on the
behavioral sensitization produced by repeated injection
of cocaine. The rats were divided into eight groups.
The two groups were pre-treated with saline [0.9% NaCl,
i.p. saline-treated rats (SAL) group; n¼4] or cocaine
[15mg/kg, i.p. cocaine-induced rats (COC) group; n¼7]
one daily for 10 consecutive days, after which time the
rats were challenged with the same dose of saline or
cocaine, 72h after the last treatment, respectively. The
acute cocaine treated group (15mg/kg, i.p. CON group;
n¼5) received saline for 10 days, after which time the
rats were challenged with cocaine, 72h after the last
treatment. The other experimental groups were pre-
treated with CR 50mg/kg (CR50þCOC group, p.o.
n¼5), CR 100mg/kg (CR100þCOC group, p.o. n¼4),
CR 200mg/kg (CR200þCOC group, p.o. n¼8), CR
400mg/kg (CR400þCOC group, p.o. n¼5) and
berberine 200mg/kg (BER200þCOC group, p.o. n¼5),
respectively, 30min before the injections of cocaine
during a 10day development phase. We did a pilot
dose–response experiment with using BER 50, 100 and
200mg/kg and we found that BER 200mg/kg produced
a maximal effect. Also, the dosage (200mg/kg) chosen in
86 Effects of CR on cocaine-induced sensitizationthis study is a relatively standard one that other workers
have reported on in a previous animal study (24).
Their locomotor activity was measured for 1h after
every injection of cocaine or saline.
Measurement of Locomotor Activity
The rats were individually housed prior to behavioral
testing. Locomotor activity was measured in a rect-
angular container (40 40 45cm
3) that was equipped
with a video camera above the center of the floor as
described previously (25). The walls and floor were made
of clear plastic and they were painted black. Locomotor
activity was monitored by a videotracking system using
the S-MART program (PanLab, Barcelona, Spain).
Rats were allowed to adapt themselves for 1h in the
container and the distance they traveled was recorded
every 10min during a 1h baseline and during a 1h after
treatment. The measure of locomotor activity was
indicated by cm.
Immunohistochemistry for Tyrosine Hydroxylase
One hour after the last behavioral testing, rats were
deeply anesthetized with sodium pentobarbital (80mg/kg,
i.p.) then perfused through the ascending aorta with
normal saline (0.9%) and this was followed by 800ml of
4% paraformaldehyde in 0.1M phosphate-buffered saline
(PBS). The brains were removed, post-fixed overnight,
cryoprotected in 20% sucrose, and cut by a cryostat as
30mm coronal sections. The sections were obtained
according to the rat atlas of Paxinos and Watson (26)
and stored in PBS solution for immunocytochemical
processing. Sections were immunostained for TH protein
by the avidin-biotin-peroxidase method. Sections were
rinsed three times for 5min each in PBS, then incubated
for 72h at 4 C with a primary polyclonal antiserum
(sheep anti-TH; Chemicon, Temecula, CA, USA) at a
titer of 1: 2000 in PBS containing 0.3% Triton-X100
(PBST). The sections were washed for 5min in PBST and
then incubated for 120min in PBST containing biotiny-
lated goat anti-sheep IgG antibody at a 1: 200 dilution
(Vector Laboratories, Burlingame, CA, USA). Following
a 90min incubation in the Elite standard vecta stain
avidin–biotin complex (ABC) re-agent (Vector
Laboratories, Burlingame, CA, USA), the sections were
again washed three times for 5min each time in PBS,
then incubated in a medium containing 0.05% 30-
diaminobenzidine tetrahydrochloride (DAB: Sigma, St
Louis, MO, USA) with 0.01% H2O2 for 1min to reveal
the immunoreactivity. Finally, the tissue was rinsed in
PBS; this was followed by a brief rinse in dH2O and the
tissues mounted individually onto slides. After allowing
the slides to air dry, they were cover-slipped. The
tegmental cells were counted at  400 magnifications
using a microscope rectangle grid that measured 50 50
microns, according to the rat atlas (26). The cells within
the tegmental areas were counted on each of three
sections per animal.
Statistical Analysis
Experimental results were expressed as means SE The
behavioral data were analyzed by one-way ANOVA
using the SPSS program (Version 8.0). Statistical
differences among groups were further analyzed using
Tukey’s post hoc test. The immunohistologic data were
calculated and analyzed by one-way ANOVA followed
by the Tukey’s post hoc technique. P values50.05 were
considered to be significant.
Results
Cocaine-induced Locomotor Activity Higher
in the Chronic Group
When the rats that were given repeated cocaine treat-
ments were then challenged with systemic administration
of cocaine, their behavioral responses were significantly
increased compared with those of the saline-induced rats
(SAL group) or acute cocaine-induced rats (CON group).
The locomotor activity across time for 1h after saline
and cocaine challenges is shown in Fig. 1. The behavioral
response to cocaine challenge in the repeated COC group
was significantly higher than that in the saline-treated
group (P50.001) and acute cocaine-treated group
(P50.001). ANOVAs (8 11, treatment time) per-
formed on the activity scores following the drug
injections indicated a significant effect of a group
difference [F (7, 35)¼79.506, P50.001], effect of day
[F (10, 350)¼1.602, P50.05], but not group day
interaction [F (70, 350)¼0.913, P¼0.672]. Tukey’s post
hoc comparisons indicated that the behavioral response
to cocaine challenge in the repeated cocaine-treated
group was significantly higher than that in the acute
cocaine treated group (P50.001).
CR and BER Significantly Blocked Chronic
Cocaine-induced Locomotor Activity
Administration of CR or BER before the cocaine
injection significantly blocked the effects of cocaine on
locomotor activity during the 60min testing period
compared with the COC group, as is seen in Fig. 1.
CR50, CR100, CR200, CR400mg/kg and BER 200mg/
kg administrated 30min before the cocaine injection
decreased the cocaine-induced locomotor activity to
eCAM 2009;6(1) 879463.6 606.7 (P¼0.154), 8115.8 201.4 (P50.05)
6052.1 399.2 (P50.001), 5273.8 186.6 (P50.001)
and 7000.3 142.9 (P50.001), respectively, when com-
pared with the COC group’s locomotor activity numbers
of 12183 618.1 [F (7,35)¼15.404, P50.001]. In a pilot
study it was shown that the only CR (100mg/kg) or BER
(100mg/kg)-treated groups did not show any change
in locomotor activity when compared with the saline-
treated group (P¼0.924, P¼0.902).
CR and BER inhibited cocaine-induced TH-like
immunoreactivity
The SAL group received saline instead of a test substance
here because the previous studies revealed that TH-like
immunoreactivity was increased due to the handling and
injection stress in a variety of brain areas. Following the
systemic injections of cocaine, a massive amount of TH
was present in the ventral tegmental area (Figs 2 and 3).
Measures of one-way ANOVAs on the numbers of
TH-like immunoreactive cells revealed a significant
difference among the groups [F (7,141)¼32.930,
P50.001). Post hoc comparisons revealed the COC
group showed more increase in the TH expression than
that of the SAL group (P50.001) and CON group
(P50.001) (Fig. 2). CR50, CR100, CR200, CR400mg/kg
and BER 200mg/kg administration 30min before the
cocaine injection decreased the numbers of TH-like
immunoreactive cells to 100.39 10.11 (P¼1.000),
90.83 5.90 (P¼0.897), 52.07 3.32 (P50.001),
44.39 2.77 (P50.001) and 59.41 9.39 (P50.001),
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Figure 1. Effect of CR and BER on the locomotor activity in cocaine-
or saline-pre-treated rats. Rats were pre-treated with saline (SAL group)
or cocaine (15mg/kg, i.p. COC group) one daily for 10 consecutive
days, after which time the rats were challenged with the same dose of
saline or cocaine, 72h after the last treatment. The acute cocaine treated
group (15mg/kg, i.p. CON group) received saline for 10 days, after
which time the rats were challenged with cocaine, 72h after the last
treatment. The other experimental groups were pre-treated with CR
50mg/kg (CR50þCOC group), CR 100mg/kg (CR100þCOC group),
CR 200mg/kg (CR200þCOC group), CR 400mg/kg (CR400þCOC
group) and berberine 200mg/kg (BER200þCOC group), 30min before
the injections of cocaine during a 10 days development phase.
Significance with Tukey’s test following a repeated ANOVA is indicated
as ***P50.001 versus SAL group and CON group, or
##P50.01,
###P50.001 versus COC group and þP50.05, þþP50.01 versus
CR50 þ COC group. The vertical lines indicate SE.
Figure 2. Representative photographs showing the TH expression in the
ventral tegmental area of SAL (A), CON (B), COC (C), CR50þCOC
(D), CR100þCOC (E), CR200þCOC (F), CR400þCOC (G) and
BER200þCOC (H) groups. The scale bar represents 25mm.
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Figure 3. Expression of TH in the ventral tegmental area after systemic
injections of saline or cocaine with Coptidis rhizoma and Berberine.
The results are presented as the mean SE. The total number of TH-
like immunoreactive neurons within a (50 50mm) grid over the areas
at 400 magnification. Significance with Tukey’s test following a
one-way ANOVA is indicated as ***P50.001 versus SAL group and
CON group, or
###P50.001 and
þþþP50.001 versus COC group.
The cells within the tegmental cell area were counted on each of three
sections per animal.
88 Effects of CR on cocaine-induced sensitizationrespectively, when compared with the COC group’s TH-
like immunoreactive cells of 100 0.
Discussion
Systemic challenge with cocaine successfully produced
a significant increase in locomotor activity and TH
immunoreactivity in the ventral tegmental area, which is
the major projection area of the central dopamine system.
The results of present study demonstrated that repeated
daily injections of cocaine produced a higher increase
in locomotor activity to a subsequent systemic challenge
with cocaine. Current results also clearly showed that a
pre-treatment with CR and BER significantly suppressed
the chronic cocaine-induced sensitization of locomotor
activity and reduced the chronic cocaine-induced
increases of TH expression in the VTA in the central
DA pathways. These findings suggest that a pre-
treatment with CR and BER reduces the development
of locomotor activity in response to cocaine by modulat-
ing dopamine synthesis in the VTA. It is well known that
the mesolimbic system from the VTA to the NAc
mediates the behavioral and reinforcing effects of cocaine
(27). In the present study, repeated injections of cocaine
produced increases in locomotor activity and increases in
the TH-like immunoreactivity in the central DA systems.
These results agree with the other previous evidence
(12,28).
The cocaine-treated group showed a significant
increase in locomotor activity, when compared with the
saline-treated group. However, there was no significant
difference in locomotor activity between the CR and
berberine only-treated groups. The CR or BER injections
did not produce any significant changes in locomotor
activity, indicating that CR or BER did not produce any
significant increase in behavioral activity. Meanwhile, the
CR and BER administered 30min prior to the cocaine
injection inhibited chronic cocaine-induced sensitization
of locomotor activity when compared with the chronic
cocaine-treated group. These results suggest that CR and
BER inhibit the chronic cocaine-induced psychologic
dependence, as determined by the behavioral sensitization
paradigm.
Current results demonstrated that pre-treatment of CR
200mg/kg and CR 400mg/kg produced a significantly
higher inhibitory effect on activity than BER 200mg/kg.
Since it is known that CR contains plamatine and
coptisine as well as BER and previous reports have
shown that palamatine and cotisine reduced behavioral
activity and DA biosynthesis (18,29,30), perhaps other
alkaloids may affect cocaine-induced neuronal and
behavioral alterations. Future analyses are needed to
investigate neurochemical and behavioral effects of these
components on cocaine-induced sensitization.
We found that a pre-treatment of CR and BER
significantly inhibited development of the cocaine-
induced behavioral sensitization and tegmental TH to
subsequent cocaine challenge. The present results also
suggest that pre-treatment of CR and BER inhibition
of the repeated cocaine-induced hyperactivity is closely
related with the inhibition of the activated dopaminergic
systems that is produced by cocaine. Therefore, the
inhibitory effect of CR and BER on behavioral activity
reflects the blockade of dopaminergic biosynthesis
or transmission. This suggestion is strongly strengthened
by previous studies showing that treatment of BER
suppressed DA biosynthesis in the brain (18,31,32).
Even though several studies have indicated that
protoberberberins may have pharmacologic effects on
the central DA system (18,23,30,31), this is the first
demonstration of BER action on cocaine-induced beha-
vioral and neurochemical activity. Little is currently
known about the action of BER on the central DA
system at cellular or molecular levels. Other kinds of
protoberberines, the tetrahydroprotoberberines (THPBs),
were previously shown to display the highest affinity for
the D1- and D2-like receptors (30,33–36). Our prelimin-
ary data suggest that BER may bind to DA-receptor sites
(unpublished observations). In addition to the clinical
study of CR or BER on cocaine addiction, further
pharmacologic actions of BER on the central dopami-
nergic systems should be investigated in the future.
Taken together, CR has been empirically prescribed as
a traditional medicine for the treatment of substance
abuse, but its major therapeutic actions have not been
well known. However, our results demonstrated that
CR and BER have central effects and thus contribute to
the restoration of a normal biochemical balance in the
dopaminergic system. Therefore, our results might
provide a mechanistic rationale for herbal treatments
including CR for treatment of drug abuse.
In summary, the present results demonstrated that CR
and BER inhibit chronic cocaine-induced sensitization
and they may modulate the cocaine-induced DA trans-
mission at both the pre- and post-synaptic levels. These
results suggest that CR and BER may be effective for
inhibiting the behavioral effects of cocaine by modulating
the central dopaminergic system.
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